A clinical trial to study the outcomes of intermittent stoppage of blood flow into the liver during donor hepatectomy for adult living donor liver transplantation using robotic approach
Not Applicable
- Conditions
- Health Condition 1: O- Medical and Surgical
- Registration Number
- CTRI/2022/04/041567
- Lead Sponsor
- Amrita Institute of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Open to Recruitment
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
All prospective male and female liver donors between 18 - 60 years of age admitted for live donor liver transplantation with right hemiliver grafts using robotic donor hepatectomy
Exclusion Criteria
(1)Prospective donors who denied consent
(2)Prospective donors of recipients with fulminant hepatic failure before liver transplantation
(3)Prospective donors for ABO-incompatible liver transplant
(4)Prospective donors of recipients who has undergone organ transplantation previously
(5)Prospective donors of recipients who are scheduled to undergo multi organ transplantation
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method To compare the blood loss during Robotic Donor Hepatectomy with and without Intermittent Inflow Occlusion [IIO] by Pringle maneuver in adult living donor liver transplantation using right hemiliver graftsTimepoint: At the end of donor surgery [Robotic Donor Hepatectomy using right hemiliver grafts]
- Secondary Outcome Measures
Name Time Method